P Iyngkaran1, M C Thomas2, C Neil3, M Jelinek4, M Cooper5, J D Horowitz6, D L Hare7, D M Kaye8. 1. Werribee Mercy Sub School, School of Medicine, Sydney, Australia. 2. Biochemistry of Diabetes Complications, Melbourne, Australia. 3. Department of Medicine-Western Precinct, University of Melbourne, Melbourne, Victoria, 3011, Australia. 4. Department of Cardiology, St. Vincent's Hospital, Melbourne, Victoria, Australia. 5. Department of Diabetes, The Alfred and Monash University, Melbourne, Australia. 6. Cardiology University of Adelaide, Adelaide, 5011, Australia. 7. Cardiovascular Research, Heart Failure Services, Austin Health, University of Melbourne, Melbourne, Victoria, Australia. 8. Cardiology and Head Heart Failure Research, Alfred Hospital, Melbourne, Australia. d.kaye@alfred.com.
Abstract
PURPOSE OF REVIEW: Heart failure with preserved ejection fraction (HFpEF) or diastolic heart failure (DHF) makes up more than half of all congestive heart failure presentations (CHF). With an ageing population, the case load and the financial burden is projected to increase, even to epidemic proportions. CHF hospitalizations add too much of the financial and infrastructure strain. Unlike systolic heart failure (SHF), much is still either uncertain or unknown. Specifically, in epidemiology, the disease burden is established; however, risk factors and pathophysiological associations are less clear; diagnostic tools are based on rigid parameters without the ability to accurately monitor treatments effects and disease progression; finally, therapeutics are similar to SHF but without prognostic data for efficacy. RECENT FINDINGS: The last several years have seen guidelines changing to account for greater epidemiological observations. Most of these remain general observation of shortness of breath symptom matched to static echocardiographic parameters. The introduction of exercise diastolic stress test has been welcome and warrants greater focus. HFpEF is likely to see new thinking in the coming decades. This review provides some of perspective on this topic.
PURPOSE OF REVIEW: Heart failure with preserved ejection fraction (HFpEF) or diastolic heart failure (DHF) makes up more than half of all congestive heart failure presentations (CHF). With an ageing population, the case load and the financial burden is projected to increase, even to epidemic proportions. CHF hospitalizations add too much of the financial and infrastructure strain. Unlike systolic heart failure (SHF), much is still either uncertain or unknown. Specifically, in epidemiology, the disease burden is established; however, risk factors and pathophysiological associations are less clear; diagnostic tools are based on rigid parameters without the ability to accurately monitor treatments effects and disease progression; finally, therapeutics are similar to SHF but without prognostic data for efficacy. RECENT FINDINGS: The last several years have seen guidelines changing to account for greater epidemiological observations. Most of these remain general observation of shortness of breath symptom matched to static echocardiographic parameters. The introduction of exercise diastolic stress test has been welcome and warrants greater focus. HFpEF is likely to see new thinking in the coming decades. This review provides some of perspective on this topic.
Authors: Kathryn Dryer; Mark Gajjar; Nikhil Narang; Margaret Lee; Jonathan Paul; Atman P Shah; Sandeep Nathan; Javed Butler; Charles J Davidson; William F Fearon; Sanjiv J Shah; John E A Blair Journal: Am J Physiol Heart Circ Physiol Date: 2018-02-09 Impact factor: 4.733
Authors: Nehal Hussain; Athanasios Charalampopoulos; Sheila Ramjug; Robin Condliffe; Charlie A Elliot; Laurence O'Toole; Andrew Swift; David G Kiely Journal: Pulm Circ Date: 2016-03 Impact factor: 3.017
Authors: Viviany R Taqueti; Scott D Solomon; Amil M Shah; Akshay S Desai; John D Groarke; Michael T Osborne; Jon Hainer; Courtney F Bibbo; Sharmila Dorbala; Ron Blankstein; Marcelo F Di Carli Journal: Eur Heart J Date: 2018-03-07 Impact factor: 29.983
Authors: Pupalan Iyngkaran; Jeff Tinsley; David Smith; Mark Haste; Kangaharan Nadarajan; Marcus Ilton; Malcolm Battersby; Simon Stewart; Alex Brown Journal: BMJ Open Date: 2014-01-29 Impact factor: 2.692
Authors: Tamara Pecherina; Anton Kutikhin; Vasily Kashtalap; Victoria Karetnikova; Olga Gruzdeva; Oksana Hryachkova; Olga Barbarash Journal: Diagnostics (Basel) Date: 2020-05-14